Northwestern Medicine scientists have uncovered how a major Parkinson's disease gene disrupts the brain's most vulnerable ...

Alzheimer's disease is a devastating neurodegenerative disorder affecting millions of people worldwide. Scientists have long ...

Well-designed nanomedicines cross the blood–brain barrier (BBB), target damaged mitochondria in neurovascular unit (NVU) cells, and suppress neuroinflammation in central nervous system (CNS) diseases.

RNA-based hTERT therapy may enhance telomere activity, improving lung cell health in pulmonary fibrosis (PF). Telomere dysfunction is a significant risk factor for PF, with telomerase reactivation ...

A new study led by Swansea University has revealed a new way to potentially treat certain autoimmune diseases by targeting a protein that helps regulate energy production in immune cells. Autoimmune ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Antibodies can now be re-engineered to work inside cells, not just on their surface, using ...

A new lipid nanoparticle platform delivers full-length antibodies inside cells, unlocking intracellular targets in cancer, autoimmune disease, and Parkinson’s.

Sickle cell disease is the scourge of a person’s red blood cells. The inherited blood disorder, which disproportionately affects people in sub-Saharan Africa and India, can cause unbearable pain ...